13 Best Drug Metabolism Startups to Watch in 2025

The Definitive Seedtable Ranking of Drug Metabolism Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 13 start-ups with an aggregate funding of $536.4m. The average funding per company in this subset is $41.3m.

Last update to the database: Feb 18, 2025. See changelog.

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up
Metabolon logo

Metabolon

Metabolon is a company developing metabolomics analytical methods and software for biomarker discovery

5

Funding Rounds

$57.1m

Money raised

Biocrates Life Sciences AG logo

Biocrates Life Sciences AG

Biocrates Life Sciences AG is an Innsbruck-based medical diagnostics company focused on metabolomic research and technology.

8

Funding Rounds

$13.6m

Money raised

ReviveMed logo

ReviveMed

ReviveMed is a biotech start-up that analyses metabolomic data using artificial intelligence, which allows them to design new medical therapeutics.

2

Funding Rounds

$1.5m

Money raised

Almac logo

Almac

Almac is a biomedical services company based in the UK founded in 1968 by Allen McClay.

2

Funding Rounds

$1.4m

Money raised

Nimbus Therapeutics logo

Nimbus Therapeutics

Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.

4

Funding Rounds

$53.0m

Money raised

Sygnature Discovery Limited logo

Sygnature Discovery Limited

Sygnature Discovery Limited is a drug Discovery Contract Research founded in 2004 by Simon Hirst.

1

Funding Rounds

Cirius Therapeutics logo

Cirius Therapeutics

Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.

1

Funding Rounds

$40.0m

Money raised

Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc.

Sagimet Biosciences Inc. is a drugs targeting the fatty acid synthase enzyme.

3

Funding Rounds

$185.0m

Money raised

SFA Therapeutics logo

SFA Therapeutics

SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.

1

Funding Rounds

$4.0m

Money raised

Poxel logo

Poxel

Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.

1

Funding Rounds

$20.3m

Money raised

Sitryx logo

Sitryx

Developer of therapeutics for chronic autoimmune and inflammatory diseases.

2

Funding Rounds

$80.0m

Money raised

Azafaros logo

Azafaros

Azafaros is a small Molecules.

1

Funding Rounds

$27.5m

Money raised

Adlai Nortye Biopharma  logo

Adlai Nortye Biopharma

Adlai Nortye Biopharma is a China-based company.

1

Funding Rounds

$53.0m

Money raised